Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia-Reference-Cited by-同舟云学术

Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia

Published:2020-05-22 Issue:3 Volume:105 Page:286-291
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Cesini Laura¹^ORCID,Frieri Camilla²,Baratè Claudia³,Sorà Federica⁴,Bonifacio Massimiliano⁵,Cerrano Marco⁶^ORCID,Cagnetta Antonia⁷,Elena Chiara⁸,Aprile Lara⁹,Sgherza Nicola¹⁰,Trawinska Malgorzata¹¹,Gozzini Antonella¹²,Capodanno Isabella¹³^ORCID,Crugnola Monica¹⁴,Carmosino Ida¹,Scalzulli Emilia¹,Ricci Federica³,Bocchia Monica⁹,Bergamaschi Micaela⁷,Aguzzi Chiara⁶,Sica Simona⁴,Galimberti Sara³,Breccia Massimo¹,Luciano Luigiana²,Latagliata Roberto¹^ORCID

Affiliation:

1. Department of Translational and Precision Medicine University “La Sapienza” of Rome Rome Italy

2. Hematology University “Federico II” of Neaples Naples Italy

3. Department of Clinical and Experimental Medicine – Hematology University of Pisa Pisa Italy

4. Hematology Catholic University of Sacred Heart of Rome Rome Italy

5. Department of Medicine Section of Hematology University of Verona Verona Italy

6. Department of Oncology and Hematology University of Turin Turin Italy

7. Clinical Hematology Policlinico San Martino Genua Italy

8. Hematology San Matteo Hospital Pavia Italy

9. Division of Hematology University of Siena Siena Italy

10. Hematology IRCCS, "Casa Sollievo della Sofferenza" San Giovanni Rotondo Italy

11. Hematology Sant’Eugenio Hospital Rome Italy

12. Hematology University of Florence Florence Italy

13. Hematology AUSL‐IRCCS Reggio Emilia Reggio Emilia Italy

14. Hematology University of Parma Parma Italy

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13436

Reference15 articles.

1. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

2. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

3. Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

4. Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life

5. Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule α-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation;Stem Cell Research & Therapy;2024-04-08

2. The Role of Erythropoietin in Myeloproliferative and Lymphoproliferative Syndromes;Comprehensive Hematology and Stem Cell Research;2024

3. Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option;Blood Reviews;2022-11

4. Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma;HemaSphere;2020-04